Thank you to Dr Misty Humphries (@mhumphriesmd), Dr Meryl Logan (@ProleneQueen) and Dr Chris Paprzycki (@CincyVascSurg) for presenting so many educational #ShockwaveIVL# cases at #VAM26#! When it comes to treating deep calcium, shockwave really excels at that.” – Dr. Misty Humphries We enjoyed the discussion around your real-world #ShockwaveE8# and #ShockwaveJavelin# cases, and are sure this session sparked calcium-cracking insights for all who attended. @VascularSVS #VascularLive# #VascSurg# Presenting physicians are paid consultants of Shockwave Medical. US Rx only. Safety Info: ​Product availability may vary by country.

#ShockwaveIVL’s# clinical evidence is different. Our predictably safe and consistently effective MOA has been validated by nearly 25,000 published patient outcomes across more than 600 scientific publications. To date, we have supported more than 70 company-led and investigator-initiated clinical studies, with an additional 50 planned between 2025 and 2029. Each study is designed to reflect the complex scenarios physicians encounter every day and to generate the clinical evidence needed to support confident adoption of Shockwave IVL. Read this new Cardiac Interventions Today article by our CMO, Nick West, to learn what our relentless commitment to research means for the future of calcium modification:  US Rx only. Safety Info:  availability may vary by country.

#ShockwaveC2Aero# continues to make waves across Northern UK and Ireland! With improved deliverability and a fast procedural flow, Shockwave C2 Aero is designed to reach and treat even the most challenging calcified coronary lesions. These first cases mark more than a launch milestone. They reflect #ShockwaveIVL’s# commitment to innovation and serve as a powerful reminder of what innovation is truly for, making complex care more achievable, consistent, and patient centered. We're proud to stand alongside UK and Irish interventional cardiologists in tackling complex coronary calcium. US Rx only. Safety Info: ​ Product availability may vary by country.

See how #ShockwaveJavelin# can spark better BTK interventions by diving into two #PeripheralIVL# case reviews recently published in Vascular Specialist. Charles Bailey, MD, George Adams, MD and Vanessa Adams, BS, describe in-depth how Shockwave Javelin successfully enabled treatment of heavily calcified BTK vessels, including distal tibial and pedal lesions. Read the article today:  Charles Bailey and George Adams are paid consultants of Shockwave Medical. US Rx only. Safety Info: Product availability may vary by country.

What happens when you compare #ShockwaveIVL# head-to-head with atherectomy in the real world? The results speak for themselves. With 1,005 patients, the ROLLING-STONE Registry is the largest prospective, multicenter study to include a head-to-head comparison of #ShockwaveIVL# and atherectomy in a real-world, all-comers population. The study confirmed strong procedural success and intraprocedural safety with Shockwave IVL. It also demonstrated a favorable 30-day MACE rate and a significantly lower 1-year MACE after propensity score matching compared with atherectomy. Read the full summary:  US Rx only. Safety Info:  Product availability may vary by country.